跳至主要内容
临床试验/NCT05963737
NCT05963737招募中不适用

PMI Guide PS Setting in Pressure Support-ventilated Patients - Prospective Multicenter Clinical RCT

Capital Medical University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
The proportion of conditions in the range of normal inspiratory effort per patient

研究概览

简要总结

Pressure support ventilation (PSV) is an assistant mechanical ventilation mode, that is widely implemented in mechanical ventilation treatment but there are no exact guidelines to guide PS setting. Traditional PS setting strategy (VT/PBW 6-8ml/kg and RR 20-30 breaths/min)has risks of excessive or insufficient assistance. Inspiratory muscle pressure index (PMI) is a noninvasive respiratory mechanical indicator and is available at the bedside. PMI was correlated with inspiratory effort and has the potential ability to predict low inspiratory effort and high inspiratory effort. The primary objective of this study is to investigate the clinical validity of a PMI-guided PS setting strategy. Specifically, the investigators aim to evaluate its impact on inspiratory effort as well as its potential for lung and diaphragm protection. Additionally, the investigators seek to assess the effect of this ventilation strategy on mechanical ventilation outcomes while evaluating the feasibility of our trial protocol.

详细描述

Pressure support ventilation (PSV) is an assistant mechanical ventilation mode to provide synchronous inspiratory support for patients with spontaneous breathing and to efficiently reduce the workload imposed on the respiratory muscle. PSV is widely implemented in mechanical ventilation treatment but there are no exact guidelines to guide PS setting. Clinicians and respiratory therapists usually adjust ventilator parameters based on tidal volume/predicted body weight (VT/PBW, 6-8ml/kg) and current respiratory rate (RR, 20-30 breaths/min). This strategy has risks of excessive or insufficient assistance because the PS setting cannot be modulated dynamically based on the requirements of ventilated patients.

Inspiratory muscle pressure index (Pmus index, PMI) is defined as the difference between plateau pressure (Pplat) and airway peak pressure (Ppeak) during end-inspiratory occlusion (EIO). PMI is a noninvasive respiratory mechanical indicator and is available at the bedside like airway occlusion pressure (P0.1) because holding operations were integrated into the majority ventilator. Several studies showed PMI was correlated with inspiratory effort. Our previous study showed PMI has the potential ability to predict low inspiratory effort and high inspiratory effort, and the optimal cut-off PMI value was approximately 0 cmH2O and 2 cmH2O.

The primary objective of this study is to investigate the clinical validity of a PMI-guided PS setting strategy. Specifically, the investigators aim to evaluate its impact on inspiratory effort as well as its potential for lung and diaphragm protection. Additionally, the investigators seek to assess the effect of this ventilation strategy on mechanical ventilation outcomes while evaluating the feasibility of our trial protocol.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients under PSV
  • Predicted ventilated time of more than 48 hours.

排除标准

  • Age less than 18 years old;
  • Known pregnancy;
  • BMI>35kg/m2;
  • Brain-stem or cervical cord injury;
  • Known or clinically suspected elevated intracranial pressure (ICP>18 mmHg);
  • Nervus phrenicus or diaphragm injury;
  • Broncho-pleural fistula;
  • Chronic obstructive pulmonary disease (COPD);
  • Pressure support ventilated time more than 48 hours before randomization.

结局指标

主要结局

The proportion of conditions in the range of normal inspiratory effort per patient

时间窗: up to 48 hours

the time from the start of PSV mode to the successful weaning of the ventilated patients

次要结局

  • Diaphragm excursion (EXdi)(up to 28 days)
  • The duration of mechanical ventilation(up to 28 days)
  • Tracheostomy rate(up to 28 days)
  • Reintubation rate(up to 28 days)
  • Diaphragm thicken fraction (TFdi)(up to 28 days)
  • inspiratory muscle pressure (Pmus)(up to 28 days)
  • number of participants with treatment-related adverse events as assessed by CTCAE v4.0(up to 28 days)
  • Diaphragm thickness (Tdi)(up to 28 days)
  • esophageal pressure time product (PTPes)(up to 28 days)

研究者

发起方
Capital Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Jian-Xin Zhou

Professor

Capital Medical University

研究点 (1)

Loading locations...

相似试验